Correlation between radioactivity and chemotherapeutics of the ¹¹¹In-VNB-liposome in pharmacokinetics and biodistribution in rats

References

• PotierPThe synthesis of navelbine prototype of a new series of vinblastine derivativesSemin Oncol1989162 Suppl 4242540531
   PubMed Web of Science ®Google Scholar
• JordanMAThrowerDWilsonLMechanism of inhibition of cell proliferation by vinca alkaloidsCancer Res1991518221222222009540
   PubMed Web of Science ®Google Scholar
• WeberBLVogelCJonesSIntravenous vinorelbine as first-line and second-line therapy in advanced breast cancerJ Clin Oncol19951311272227307595730
   PubMed Web of Science ®Google Scholar
• GridelliCDe VivoRVinorelbine in the treatment of non-small cell lung cancerCurr Med Chem20029887989111966450
   PubMed Web of Science ®Google Scholar
• DrummondDCNobleCOGuoZImproved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbineJ Pharmacol Exp Ther2009328132133018948499
   PubMed Web of Science ®Google Scholar
• BawejaMSumanVJFitchTRPhase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG studyAnn Oncol200617462362916520332
   PubMed Web of Science ®Google Scholar
• OkounevaTHillBTWilsonLJordanMAThe effects of vinflunine, vinorelbine, and vinblastine on centromere dynamicsMol Cancer Ther20032542743612748304
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
   PubMed Web of Science ®Google Scholar
• PhillipsWTGoinsBBaoARadioactive liposomesWiley Interdiscip Rev Nanomed Nanobiotechnol200911698320049780
   PubMed Web of Science ®Google Scholar
• TingGChangCHWangHELeeTWNanotargeted radionuclides for cancer nuclear imaging and internal radiotherapyJ Biomed Biotechnol2010 953537
   Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev200542145160
   Google Scholar
• AllenTMBrandeisEHansenCBKaoGYZalipskySA new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cellsBiochim Biophys Acta199512372991087632714
   PubMed Web of Science ®Google Scholar
• DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev199951469174310581328
   PubMed Web of Science ®Google Scholar
• HamoudehMKamlehMADiabRFessiHRadionuclide delivery systems for nuclear imaging and radiotherapy of cancerAdv Drug Deliv Rev200860121329134618562040
   PubMed Web of Science ®Google Scholar
• TingGChangCHWangHECancer nanotargeted radiopharmaceuticals for tumor imaging and therapyAnticancer Res200929104107411819846958
   PubMed Web of Science ®Google Scholar
• DanceyJEChenHXStrategies for optimizing combinations of molecularly targeted anticancer agentsNat Rev200658649659
   Google Scholar
• ChoyHKimDWChemotherapy and irradiation interactionSemin Oncol2003304 Suppl 931012908132
   PubMed Web of Science ®Google Scholar
• JainRKNormalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapyNat Med20017998798911533692
   PubMed Web of Science ®Google Scholar
• HuberPEBischofMJenneJTrimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapyCancer Res20056593643365515867359
   PubMed Web of Science ®Google Scholar
• WongJYSystemic targeted radionuclide therapy: potential new areasInt J Radiat Oncol Biol Phys200666Suppl 2S748216979445
   PubMed Web of Science ®Google Scholar
• ChowTHLinYYHwangJJTherapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imagingJ Nucl Med200950122073208119949027
   PubMed Web of Science ®Google Scholar
• ChowTHLinYYHwangJJDiagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal modelNucl Med Biol200835562363418589307
   PubMed Web of Science ®Google Scholar
• ChowTHLinYYHwangJJImprovement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse modelAnticancer Res20092962111212019528471
   PubMed Web of Science ®Google Scholar
• LeeWCHwangJJTsengYLTherapeutic efficacy evaluation of 111In-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenograftsNucl Instrum Meth A2006569497504
   Web of Science ®Google Scholar
• LinYYLiJJChangCHEvaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse modelCancer Biother Radiopharms2009244453460
   PubMed Web of Science ®Google Scholar
• ChangYJChangCHYuCYTherapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor modelNucl Med Biol20103719510420122674
   PubMed Web of Science ®Google Scholar
• ChenLCChangCHYuCYPharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice modelNucl Med Biol200835888389319026950
   PubMed Web of Science ®Google Scholar
• ChenMHChangCHChangYJMicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing miceAnticancer Res2010301657220150618
   PubMed Web of Science ®Google Scholar
• HsiehYJChangCHHuangSPEffect of cyclosporin A on the brain regional distribution of doxorubicin in ratsInt J Pharm20083501–226527117935917
   PubMed Web of Science ®Google Scholar
• WuYTHuangCMLinCCDetermination of melamine in rat plasma, liver, kidney, spleen, bladder and brain by liquid chromatography-tandem mass spectrometryJ Chromatogr A20091216447595760119493536
   PubMed Web of Science ®Google Scholar
• SempleSCLeoneRWangJOptimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activityJ Pharm Sci20059451024103815793796
   PubMed Web of Science ®Google Scholar
• WebbMSJohnstoneSMorrisTJIn vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserineEur J Pharm Biopharm200765328929917123800
   PubMed Web of Science ®Google Scholar
• HongRLHuangCJTsengYLDirect comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?Clin Cancer Res19995113645365210589782
   PubMed Web of Science ®Google Scholar
• KobayashiSSakaiTDalrymplePDWoodSGChasseaudLFDisposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogsArzneimittelforschung19934312136713778141830
   PubMed Web of Science ®Google Scholar
• ChoiceEMasinDBallyMBMelocheMMaddenTDLiposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistributionTransplantation1995609100610117491673
   PubMed Web of Science ®Google Scholar
• GabizonAIsacsonRLibsonEClinical studies of liposome-encapsulated doxorubicinActa Oncol19943377797867993646
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHBarenholzYPharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studiesClin Pharmacokinet200342541943612739982
   PubMed Web of Science ®Google Scholar
• KleiterMMYuDMohammadianLAA tracer dose of technetium-99 m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasationClin Cancer Res200612226800680717121901
   PubMed Web of Science ®Google Scholar
• KereiakesJGRaoDVAuger electron dosimetry: report of AAPM Nuclear Medicine Committee Task Group No. 6Med Phys199219613591461197
   PubMed Web of Science ®Google Scholar